These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15366459)

  • 21. [Selective vasodilation in the lung. Sildenafil improves physical capacity and prognosis].
    MMW Fortschr Med; 2007 May; 149(22):45. PubMed ID: 18069228
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary arterial pulmonary hypertension and sildenafil: a case report from Dakar].
    Bouldouyre M; Dia D; Ba FK; Diop IB; Debonne JM
    Dakar Med; 2006; 51(2):78-80. PubMed ID: 17632981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
    Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
    Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation.
    Makisalo H; Koivusalo A; Vakkuri A; Hockerstedt K
    Liver Transpl; 2004 Jul; 10(7):945-50. PubMed ID: 15237383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.
    Saygili A; Canter B; Iriz E; Kula S; Tunaoğlu FS; Olguntürk R; Ozdoğan ME
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):775-6. PubMed ID: 15650993
    [No Abstract]   [Full Text] [Related]  

  • 27. Sildenafil in pulmonary arterial hypertension.
    Confalonieri M; Antonaglia V; Lucangelo U; Gullo A
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1256; author reply 1256-7. PubMed ID: 15161616
    [No Abstract]   [Full Text] [Related]  

  • 28. Sildenafil for "blue babies". Ethics, conscience, and science have to be balanced against limited resources.
    Patole S; Travadi J
    BMJ; 2002 Nov; 325(7373):1174. PubMed ID: 12434819
    [No Abstract]   [Full Text] [Related]  

  • 29. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sildenafil in pulmonary hypertension: the opinion of pediatric cardiologist].
    Micheletti A; Butera G; Chessa M; Carminati M
    Pediatr Med Chir; 2008; 30(3):159-62. PubMed ID: 19024861
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
    Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
    Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil and pulmonary hypertension in children.
    Prescrire Int; 2012 Jul; 21(129):178. PubMed ID: 22852281
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil as treatment for Human Immunodeficiency Virus-related pulmonary hypertension in a child.
    Wong AR; Rasool AH; Abidin NZ; Noor AR; Quah BS
    J Paediatr Child Health; 2006 Mar; 42(3):147-8. PubMed ID: 16509918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation.
    Gómez-Moreno S; Lage E; Hernández A; Campos A; Cabezón S; Ordóñez A; Hinojosa R
    Transplant Proc; 2005 Apr; 37(3):1550-1. PubMed ID: 15866670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Sildenafil in the management of primary pulmonary hypertension.
    Malhotra S; Punia VP
    J Assoc Physicians India; 2004 Aug; 52():670-2. PubMed ID: 15847367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
    Sheth A; Park JE; Ong YE; Ho TB; Madden BP
    Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil for lung fibrosis and pulmonary hypertension.
    Kleinsasser A; Loeckinger A
    Lancet; 2003 Jan; 361(9353):262-3; author reply 263. PubMed ID: 12547578
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
    Condò V; Colnaghi MR; Mosca E
    Pediatr Med Chir; 2008; 30(3):156-8. PubMed ID: 19024860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.